tradingkey.logo

Sciwind Biosciences GLP-1 drug approved in China for weight management

ReutersMar 6, 2026 4:43 AM

- Sciwind Biosciences' GLP-1 injection ecnoglutide has been approved for use in China for chronic weight management in adults who are overweight or obese, the company said in a statement on its website Friday.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI